bio-restorative-therapies-logo-final[1].png
BioRestorative Therapies Receives FDA Clearance to Initiate Phase 2 Clinical Trial for the Treatment of Patients with Degenerative Disc Disease
08 févr. 2017 09h45 HE | BioRestorative Therapies, Inc.
MELVILLE, N.Y., Feb. 08, 2017 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BRT" or the “Company") (OTCBB:BRTX), a life sciences company focused on stem cell-based therapies, today announced...
bio-restorative-therapies-logo-final[1].png
BioRestorative Therapies Submits IND Application to FDA to Treat Patients with Degenerative Disc Disease
09 janv. 2017 09h45 HE | BioRestorative Therapies, Inc.
MELVILLE, N.Y., Jan. 09, 2017 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BRT" or the “Company") (OTCBB:BRTX), a life sciences company focused on stem cell-based therapies, today announced...
bio-restorative-therapies-logo-final[1].png
BioRestorative Therapies Announces Publication in Medical Journal of Positive Results of Long-Term Safety and Feasibility Study Using Cell Therapy to Treat Patients with Degenerative Disc Disease
12 sept. 2016 09h45 HE | BioRestorative Therapies, Inc.
MELVILLE, N.Y., Sept. 12, 2016 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BRT" or the “Company") (OTCBB:BRTX), a life sciences company focused on stem cell-based therapies, today announced...
bio-restorative-therapies-logo-final[1].png
BioRestorative Therapies Announces Presentation at 3rd Annual Regenerative Medicine Essentials Course
13 juil. 2016 10h46 HE | BioRestorative Therapies, Inc.
MELVILLE, N.Y., July 13, 2016 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BRT" or the “Company") (OTCBB:BRTX), a life sciences company focused on stem cell-based therapies, today announced...
bio-restorative-therapies-logo-final[1].png
BioRestorative Therapies Announces Completion of Human Safety and Feasibility Study on the Use of Hypoxic Cultured Stem Cells to Treat Chronic Lower Back Pain
28 juin 2016 09h45 HE | BioRestorative Therapies, Inc.
MELVILLE, N.Y., June 28, 2016 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BRT" or the “Company") (OTCBB:BRTX), a life sciences company focused on stem cell-based therapies, today announced...
bio-restorative-therapies-logo-final[1].png
BioRestorative Therapies to Present at 5th Annual Marcum MicroCap Conference
31 mai 2016 09h45 HE | BioRestorative Therapies, Inc.
MELVILLE, N.Y., May 31, 2016 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BRT" or the “Company") (OTCBB:BRTX), a life sciences company focused on stem cell-based therapies, today announced...
bio-restorative-therapies-logo-final[1].png
BioRestorative Therapies Announces Promising Data to Advance its Program for the Treatment of Metabolic Disorders
23 mai 2016 09h45 HE | BioRestorative Therapies, Inc.
MELVILLE, N.Y., May 23, 2016 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BRT" or "the Company") (OTCBB:BRTX), a life sciences company focused on stem cell-based therapies, today announced...
bio-restorative-therapies-logo-final[1].png
BioRestorative Therapies Deepens Board of Directors With Addition of Robert B. Catell, Former Chairman and CEO of KeySpan Corporation and Chairman of National Grid, US
23 févr. 2016 09h45 HE | BioRestorative Therapies, Inc.
MELVILLE, N.Y., Feb. 23, 2016 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BRT" or the “Company") (OTCBB:BRTX), a life sciences company focused on stem cell-based therapies, today announced...
bio-restorative-therapies-logo-final[1].png
BioRestorative Therapies Names Lead Cell-Based Lumbar Disc Therapeutic Product
09 févr. 2016 08h00 HE | BioRestorative Therapies, Inc.
MELVILLE, N.Y., Feb. 09, 2016 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BRT" or the “Company") (OTCBB:BRTX), a life sciences company focused on stem cell-based therapies, today announced...
bio-restorative-therapies-logo-final[1].png
BioRestorative Therapies Provides Company Updates With Shareholder Letter
21 déc. 2015 08h00 HE | BioRestorative Therapies, Inc.
MELVILLE, N.Y., Dec. 21, 2015 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (OTCBB:BRTX), a life sciences company focused on stem cell-based therapies, today announced the...